1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016

Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Clinical Chemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Clinical Chemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Clinical Chemistry Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Clinical Chemistry Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Clinical Chemistry Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 Clinical Chemistry Analyzers Overview 10
3 Products under Development 11
3.1 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 11
3.2 Clinical Chemistry Analyzers - Pipeline Products by Segment 12
3.3 Clinical Chemistry Analyzers - Pipeline Products by Territory 13
3.4 Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 14
3.5 Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 15
4 Clinical Chemistry Analyzers - Pipeline Products under Development by Companies 16
4.1 Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development 16
4.2 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 18
5 Clinical Chemistry Analyzers Companies and Product Overview 19
5.1 Analyticon Biotechnologies AG Company Overview 19
5.1.1 Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 19
5.2 Ativa Medical Inc. Company Overview 23
5.2.1 Ativa Medical Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
5.3 Aviv Biomedical, Inc. Company Overview 25
5.3.1 Aviv Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
5.4 Beacon Biotechnology Company Overview 26
5.4.1 Beacon Biotechnology Pipeline Products and Ongoing Clinical Trials Overview 26
5.5 Curetis N.V. Company Overview 27
5.5.1 Curetis N.V. Pipeline Products and Ongoing Clinical Trials Overview 27
5.6 Daxor Corporation Company Overview 29
5.6.1 Daxor Corporation Pipeline Products and Ongoing Clinical Trials Overview 29
5.7 DiaSys Diagnostic Systems GmbH Company Overview 30
5.7.1 DiaSys Diagnostic Systems GmbH Pipeline Products and Ongoing Clinical Trials Overview 30
5.8 EMERGENT DETECTION INC Company Overview 32
5.8.1 EMERGENT DETECTION INC Pipeline Products and Ongoing Clinical Trials Overview 32
5.9 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 33
5.9.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products and Ongoing Clinical Trials Overview 33
5.10 Illumina, Inc. Company Overview 35
5.10.1 Illumina, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
5.11 Intelligent Fingerprinting Ltd Company Overview 37
5.11.1 Intelligent Fingerprinting Ltd Pipeline Products and Ongoing Clinical Trials Overview 37
5.12 I-Sens Inc. Company Overview 38
5.12.1 I-Sens Inc. Pipeline Products and Ongoing Clinical Trials Overview 38
5.13 MyCartis NV Company Overview 40
5.13.1 MyCartis NV Pipeline Products and Ongoing Clinical Trials Overview 40
5.14 NanoIVD Inc (Inactive) Company Overview 42
5.14.1 NanoIVD Inc (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 42
5.15 National Institute of Biomedical Imaging and Bioengineering Company Overview 43
5.15.1 National Institute of Biomedical Imaging and Bioengineering Pipeline Products and Ongoing Clinical Trials Overview 43
5.16 NeuMoDx Molecular, Inc Company Overview 44
5.16.1 NeuMoDx Molecular, Inc Pipeline Products and Ongoing Clinical Trials Overview 44
5.17 OPKO Health, Inc. Company Overview 45
5.17.1 OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
5.18 OptiCul Diagnostics Ltd. Company Overview 47
5.18.1 OptiCul Diagnostics Ltd. Pipeline Products and Ongoing Clinical Trials Overview 47
5.19 Renishaw Plc Company Overview 48
5.19.1 Renishaw Plc Pipeline Products and Ongoing Clinical Trials Overview 48
5.20 Rheonix, Inc. Company Overview 50
5.20.1 Rheonix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
5.21 Samsung Electronics Co., Ltd. Company Overview 51
5.21.1 Samsung Electronics Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 51
5.22 Sekisui Diagnostics, LLC. Company Overview 53
5.22.1 Sekisui Diagnostics, LLC. Pipeline Products and Ongoing Clinical Trials Overview 53
5.23 Smiths Detection Group Limited Company Overview 54
5.23.1 Smiths Detection Group Limited Pipeline Products and Ongoing Clinical Trials Overview 54
5.24 The Hong Kong University of Science and Technology Company Overview 56
5.24.1 The Hong Kong University of Science and Technology Pipeline Products and Ongoing Clinical Trials Overview 56
5.25 Theranos Inc Company Overview 57
5.25.1 Theranos Inc Pipeline Products and Ongoing Clinical Trials Overview 57
5.26 Thermal Gradient, Inc. Company Overview 59
5.26.1 Thermal Gradient, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
6 Clinical Chemistry Analyzers- Recent Developments 60
6.1 Nov 10, 2016: Siemens Healthcare Plans IPO 60
6.2 Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer 60
6.3 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 60
6.4 Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016 61
6.5 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 62
6.6 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 63
6.7 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016 64
6.8 Nov 02, 2016: Lak Ananth to head new next47 startup unit 67
6.9 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 68
6.10 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016 69
6.11 Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit 70
6.12 Nov 01, 2016: IDEXX Laboratories Announces Third Quarter Results 70
6.13 Nov 01, 2016: Introducing Renishaw's new RA802 Pharmaceutical Analyser 73
6.14 Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 73
6.15 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 74
6.16 Oct 25, 2016: Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2017 75
6.17 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 77
6.18 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 79
6.19 Oct 19, 2016: IDEXX Laboratories Elects Lawrence D. Kingsley to Board of Directors 82
6.20 Oct 18, 2016: Agenix: US sales and key appointment 82
6.21 Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors 82
6.22 Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution 83
6.23 Oct 17, 2016: New design of hematology and clinical chemistry analyzers 84
6.24 Oct 14, 2016: Agenix: Appointment of Independent Non- Executive Directors 84
6.25 Oct 12, 2016: Danaher to Acquire Phenomenex 84
6.26 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 85
6.27 Oct 03, 2016: Boule Diagnostics Raises Funds in Private Placement of Shares 85
6.28 Sep 26, 2016: PerkinElmer Announces New Organizational Structure 85
6.29 Sep 24, 2016: Proxima Demonstrated at NVIC Congress Following Significant Sale in Benelux 85
6.30 Sep 23, 2016: Siegfried Russwurm to resign by mutual agreement from the Siemens Management Board 86
6.31 Sep 15, 2016: Unique in-line blood gas analyser selected to feature in BACCN annual conference Simulation Lab 86
6.32 Sep 14, 2016: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 87
6.33 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 87
6.34 Sep 12, 2016: Patient-dedicated blood gas analysis enhances flu readiness and infection control 87
6.35 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 88
6.36 Sep 07, 2016: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 90
6.37 Sep 07, 2016: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 91
6.38 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 92
6.39 Sep 02, 2016: Danaher Acquires Cepheid 92
6.40 Aug 31, 2016: bioMerieux - First-Half 2016 Results 93
6.41 Aug 30, 2016: Sphere Medical expands sales into Belgium 96
6.42 Aug 30, 2016: AGENIX Announces Annual Result For The Year Ended 30 June 2016 97
6.43 Aug 19, 2016: Curetis Reports Financial Results for the First Six Months of 2016 98
6.44 Aug 18, 2016: Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 100
6.45 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 100
6.46 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings 101
6.47 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 102
6.48 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 103
6.49 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 105
6.50 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 106
6.51 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 107
6.52 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 111
6.53 Jul 28, 2016: Illumina Names Philip W. Schiller to its Board of Directors 112
6.54 Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results 112
6.55 Jul 28, 2016: QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017 113
6.56 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 116
6.57 Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 116
6.58 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results 117
6.59 Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors 118
6.60 Jul 26, 2016: Mindray and MedTest announce FDA 510(k) Clearance for the BA-800M Clinical Chemistry Analyzer 118
6.61 Jul 26, 2016: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2016 119
6.62 Jul 25, 2016: Abingdon Health announces GMP compliant facilities and registration with U.S. FDA 120
6.63 Jul 21, 2016: Abaxis Reports Financial Performance for the First Quarter of Fiscal 2017 and Declares a Quarterly Cash Dividend 120
6.64 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 122
6.65 Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts 124
6.66 Jul 18, 2016: bioMerieux - Second-Quarter 2016 Business Review 125
6.67 Jul 14, 2016: microDimensions Raises Funds in Series A Financing Round 128
6.68 Jul 12, 2016: PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 128
6.69 Jul 11, 2016: Abingdon Health Raises USD4 Million in Venture Financing 128
6.70 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director 129
6.71 Jul 07, 2016: Enzo Biochem's Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina 129
6.72 Jul 06, 2016: Luminex Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System 129
6.73 Jul 04, 2016: Exiqon - Nomination of candidates for the supervisory board 130
6.74 Jul 04, 2016: Curetis Appoints Christopher M. Bernard as Chief Executive Officer of Newly-Formed U.S. Subsidiary 130
6.75 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 131
6.76 Jun 17, 2016: Daxor Announces Hiring of Chief Financial Officer 132
6.77 Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 132
6.78 Jun 14, 2016: Proxima interface to Conworx data management solutions enables seamless data transfer from ex-vivo analyser 132
6.79 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market 133
6.80 Jun 10, 2016: Diadexus to File Chapter 7 133
6.81 Jun 06, 2016: Curetis and Axonlab sign multi-market European distribution agreement 134
6.82 Jun 02, 2016: EKF Diagnostics Raises USD7 Million in Private Placement of Shares 134
6.83 Jun 02, 2016: Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa 134
6.84 May 31, 2016: ERBA Diagnostics Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors 135
6.85 May 20, 2016: ERBA Diagnostics Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan 135
6.86 May 20, 2016: Curetis Publishes First Quarter 2016 Business and Financial Update 136
6.87 May 12, 2016: Akers Biosciences: Financial Results for the First Quarter 2016 137
6.88 May 12, 2016: Akers Biosciences Reports Earnings for Q1 2016 139
6.89 May 12, 2016: Boule Diagnostics Interim report January-March 2016 142
6.90 May 11, 2016: Clarissa Haller new head of communications at Siemens 143
6.91 May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility 143
6.92 May 09, 2016: EKF Diagnostics Announces Directorate Change 144
6.93 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results 144
6.94 May 04, 2016: Earnings Release and Financial Results Q2 FY 2016: Continuing growth in orders, revenue and profitability 145
6.95 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results 145
6.96 Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change 148
6.97 Apr 18, 2016: NanoIVD Announces 510(k) Pre-Sub Supplement on PanOnco Check 148
6.98 Apr 12, 2016: EKF Diagnostics Holdings: Final results 149
6.99 Apr 07, 2016: Luminex to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting 152
6.100 Mar 23, 2016: STRATEC Biomedical to Acquire Diatron from Riverside Company 153
6.101 Mar 16, 2016: New Luna Omega 1.6 Micron Particle Brings Acclaimed Capabilities to UHPLC 153
6.102 Mar 14, 2016: Instrumentation Laboratory Reports Record Worldwide Sales In 2015 154
6.103 Mar 01, 2016: HORIBA: Alliance'2016 155
6.104 Feb 23, 2016: Thermo Fisher Scientific Exhibits ClinQuan MD Software for In Vitro Diagnostic Use at MSACL 2016 155
6.105 Feb 18, 2016: Boule Diagnostics: Year-end report 2015 155
6.106 Feb 12, 2016: DiaSys Diagnostic Systems presents QDx Lipidcheck at Arab Health in January 2016 156
6.107 Feb 09, 2016: HORIBA Formulates New Mid-Long Term Management Plan MLMAP2020 157
6.108 Feb 02, 2016: Life Line Screening Enters Into Multi-Year Contract Extension for CardioChek Family of Lipid and Glucose Products 158
6.109 Jan 29, 2016: IDEXX Laboratories Announces Fourth Quarter and Full Year 2015 Results 158
6.110 Jan 26, 2016: Sphere Medical Holding: Contract Win 160
6.111 Jan 26, 2016: Premaitha Health: Update on UK Litigation Timing 161
6.112 Jan 20, 2016: EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016 161
6.113 Dec 03, 2015: Patient-dedicated blood gas analyser for use in winter flu isolation beds 162
7 Appendix 163
7.1 Methodology 163
7.2 About GlobalData 166
7.3 Contact Us 166
7.4 Disclaimer 166

1.1 List of Tables
Table 1: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 11
Table 2: Clinical Chemistry Analyzers - Pipeline Products by Segment 12
Table 3: Clinical Chemistry Analyzers - Pipeline Products by Territory 13
Table 4: Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 14
Table 5: Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 15
Table 6: Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development 16
Table 7: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 18
Table 8: Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 19
Table 9: Biolyzer 100 - Product Status 19
Table 10: Biolyzer 100 - Product Description 20
Table 11: Biolyzer 300 - Product Status 20
Table 12: Biolyzer 300 - Product Description 21
Table 13: Biolyzer 600 - Product Status 21
Table 14: Biolyzer 600 - Product Description 22
Table 15: Ativa Medical Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
Table 16: Ativa Micro-Lab System - Product Status 23
Table 17: Ativa Micro-Lab System - Product Description 24
Table 18: Aviv Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
Table 19: Bili-4 Hematofluorometer - Product Status 25
Table 20: Bili-4 Hematofluorometer - Product Description 25
Table 21: Beacon Biotechnology Pipeline Products and Ongoing Clinical Trials Overview 26
Table 22: BrightSPOT - Product Status 26
Table 23: BrightSPOT - Product Description 26
Table 24: Curetis N.V. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 25: Unyvero Analyzer - Product Status 27
Table 26: Unyvero Analyzer - Product Description 28
Table 27: Daxor Corporation Pipeline Products and Ongoing Clinical Trials Overview 29
Table 28: Total Blood Volume Analyzer - Total Body Albumin - Product Status 29
Table 29: Total Blood Volume Analyzer - Total Body Albumin - Product Description 29
Table 30: DiaSys Diagnostic Systems GmbH Pipeline Products and Ongoing Clinical Trials Overview 30
Table 31: QDx Lipidcheck - Product Status 30
Table 32: QDx Lipidcheck - Product Description 30
Table 33: respons940 - Product Status 31
Table 34: respons940 - Product Description 31
Table 35: EMERGENT DETECTION INC Pipeline Products and Ongoing Clinical Trials Overview 32
Table 36: BodyKey Fat Loss Sensor - Product Status 32
Table 37: BodyKey Fat Loss Sensor - Product Description 32
Table 38: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products and Ongoing Clinical Trials Overview 33
Table 39: Paper-Based Microfluidic Analytical System - Product Status 33
Table 40: Paper-Based Microfluidic Analytical System - Product Description 34
Table 41: Illumina, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 42: LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status 35
Table 43: LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description 36
Table 44: Intelligent Fingerprinting Ltd Pipeline Products and Ongoing Clinical Trials Overview 37
Table 45: Intelligent Fingerprinting - Product Status 37
Table 46: Intelligent Fingerprinting - Product Description 37
Table 47: I-Sens Inc. Pipeline Products and Ongoing Clinical Trials Overview 38
Table 48: Blood Gas Analyzer - Product Status 38
Table 49: Blood Gas Analyzer - Product Description 39
Table 50: MyCartis NV Pipeline Products and Ongoing Clinical Trials Overview 40
Table 51: Evalution - Product Status 40
Table 52: Evalution - Product Description 41
Table 53: NanoIVD Inc (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 42
Table 54: NanoIVD Clinical Analyzer-I - Product Status 42
Table 55: NanoIVD Clinical Analyzer-I - Product Description 42
Table 56: National Institute of Biomedical Imaging and Bioengineering Pipeline Products and Ongoing Clinical Trials Overview 43
Table 57: Microfluidic Diagnostic Card - Product Status 43
Table 58: Microfluidic Diagnostic Card - Product Description 43
Table 59: NeuMoDx Molecular, Inc Pipeline Products and Ongoing Clinical Trials Overview 44
Table 60: NeuMoDx 500 Molecular IVD System - Product Status 44
Table 61: NeuMoDx 500 Molecular IVD System - Product Description 44
Table 62: OPKO Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
Table 63: Claros 1 Analyzer - Product Status 45
Table 64: Claros 1 Analyzer - Product Description 46
Table 65: OptiCul Diagnostics Ltd. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 66: Optidet Multi - Product Status 47
Table 67: Optidet Multi - Product Description 47
Table 68: Renishaw Plc Pipeline Products and Ongoing Clinical Trials Overview 48
Table 69: RenDx Multiplex Assay System - Product Status 48
Table 70: RenDx Multiplex Assay System - Product Description 49
Table 71: Rheonix, Inc. Pipeline Products and Ongoing Clinical Trials Overview 50
Table 72: EncompassMDx Platform - Product Status 50
Table 73: EncompassMDx Platform - Product Description 50
Table 74: Samsung Electronics Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 75: LABGEO PT10 - Product Status 51
Table 76: LABGEO PT10 - Product Description 52
Table 77: Sekisui Diagnostics, LLC. Pipeline Products and Ongoing Clinical Trials Overview 53
Table 78: SK500 Clinical Chemistry System - Product Status 53
Table 79: SK500 Clinical Chemistry System - Product Description 53
Table 80: Smiths Detection Group Limited Pipeline Products and Ongoing Clinical Trials Overview 54
Table 81: Bio-Seeq - Clinical - Product Status 54
Table 82: Bio-Seeq - Clinical - Product Description 55
Table 83: The Hong Kong University of Science and Technology Pipeline Products and Ongoing Clinical Trials Overview 56
Table 84: Portable Real-time PCR System - Product Status 56
Table 85: Portable Real-time PCR System - Product Description 56
Table 86: Theranos Inc Pipeline Products and Ongoing Clinical Trials Overview 57
Table 87: miniLab System - Product Status 57
Table 88: miniLab System - Product Description 58
Table 89: Thermal Gradient, Inc. Pipeline Products and Ongoing Clinical Trials Overview 59
Table 90: Flash HT - Product Status 59
Table 91: Flash HT - Product Description 59
Table 92: Glossary 164

1.2 List of Figures
Figure 1: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development 11
Figure 2: Clinical Chemistry Analyzers - Pipeline Products by Segment 12
Figure 3: Clinical Chemistry Analyzers - Pipeline Products by Territory 13
Figure 4: Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path 14
Figure 5: Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date 15

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 23500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging ...

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

  • $ 23500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com new ...

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

  • $ 21800
  • Industry report
  • October 2016
  • by Venture Planning Group

The new seven-country market intelligence and technology assessment study from VPGMarketResearch.com was designed to help current suppliers and potential market entrants identify and evaluate emerging ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.